Tiopronino
CAS NO. | 95-25-0 |
MOQ | 1kg |
ŝtopaĵo | 5kg / stano |
transdono Tempo | Ene 30 tagoj |
Pago-reĝimo | negociable |
provizo kapablo | 1T / monato |
uzado
For early treatment of viral hepatitis, alcoholic hepatitis, drug-induced hepatitis, heavy metal toxic hepatitis, fatty liver and liver cirrhosis. It can reduce the side effects of radiotherapy and chemotherapy, and can prevent the occurrence of secondary tumors caused by radiotherapy. It has a significant therapeutic effect on senile early cataract. It has anti-inflammatory and anti-allergic effects, and has a good effect on dermatitis, eczema, acne and urticaria
Produkto avantaĝo
AperasraNCE | White Crystal powder |
punkto de fandado | 96.0℃~ 96.5℃ |
PH | 1.5 ~ 3.0 |
rilataj substancoj | ≤1.0% |
Perdo sur sekigita | ≤0.5% |
Residuo ĉe sparkado | ≤0.1% |
peza Metalo | ≤10PPM |
Sulfato | ≤0.05% |
Ferra salo | ≤5PPM |
Arsena salo | ≤2PPM |
Assay | ≥98.0% |